Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia (CHIME)

University of Virginia

Status: Unknown

Conditions: Hepatitis C

Treatments: Other: Hepatitis C treatment as chosen by provider

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03876470

21167

Details and patient eligibility

About

The objective of this protocol is to conduct a comprehensive quantitative and qualitative assessment of the impact of our innovative collaborative telehealth HCV care model on patient treatment experiences and quality of life.

Full description

The investigators will evaluate the proportion of patients at each step of the HCV care cascade before and after implementation of the collaborative care model. Additionally, participants will complete questionnaires at three time points: at the initiation of hepatitis C treatment, at treatment completion, and at the assessment of sustained virologic response. Questionnaires will assess quality of life, mental health, chronic liver disease outcomes, and substance use. A subset of participants will also complete semi-structured interviews at each of the three time points. Then, a smaller subset of participants will be selected for a detailed ethnographic case study focusing on treatment experiences, quality of life, forms of social support, and illness experience.

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years or older
• Detectable HCV viral load
• Attended a clinic appointment at one of our participating sites

Exclusion criteria

• Cognitive disability such that informed consent cannot be obtained
• Prisoners
• Unable to understand English

Trial design

300 participants in 1 patient group

All Participants

Description:

All participants will receive HCV treatment as determined by their provider. HCV treatment is not assigned by the study.

Treatment:

Other: Hepatitis C treatment as chosen by provider